Alison L. Hannah - May 14, 2021 Form 4 Insider Report for RIGEL PHARMACEUTICALS INC (RIGL)

Role
Director
Signature
/s/ Dolly Vance (Attorney-in-Fact)
Stock symbol
RIGL
Transactions as of
May 14, 2021
Transactions value $
$0
Form type
4
Date filed
5/18/2021, 07:01 PM
Next filing
May 21, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RIGL Stock Option (Right to Buy) Award $0 +80K $0.00 80K May 14, 2021 Common Stock 80K $3.71 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shall vest in equal monthly installments over the shorter of three years from the date of grant or the period beginning on the date the Reporting Person was appointed to the Company's Board of Directors and ending on the date of the annual meeting at which the Reporting Person is first considered for election by the stockholders, provided that the Reporting Person continues to provide service.